Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to transform care MONTRÉAL, QUEBEC / ACCESS Newswire / July 2, 2025 / A ...

Sensifai emerges from stealth with a landmark peer-reviewed study in The Lancet Digital Health, validating its world-first AI platform to detect inflammatory events before symptoms, redefining how and ...

A bucket of water in your AC room won’t save your lungs in fact, it might make things worse. Pulmonologist Dr Vikas Mittal ...

Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...

A coroner wants medicine dispensing records centralised after he found a mistake with a morphine prescription may have contributed to a Levin woman's death.

The Jacobs School of Medicine and Biomedical Sciences had a strong showing at this year’s American Thoracic Society (ATS) 2025 annual conference in San Francisco in May, where a team of researchers ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

Columnist Caroline Gainer weighs in on how changes with her doctors have affected her ability to coordinate care for her COPD ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...